Clinical Evaluation of “Feiji Decoction” in Treating Non-small Cell Lung Cancer in 61 Cases
Jie You
Abstract
Jie You
Abstract
To observe the clinical efficacy of “Feiji Decoction” in the treatment of non small cell lung cancer(NSCLC), 102 subjects were randomized into two groups: observation group in which 61 cases were treated with “Feiji Decoction” and chemotherapy and control group in which 41 cases were treated with simple chemotherapy. The clinical symptoms, survival quality scale and specific lung cancer module were observed. Results: After treatment, the symptoms were alleviated in observation group and tended to worsen in control group. Conclusion: “Feiji Decoction” can relieve NSELC symptoms and its chemotherapeutic symptoms.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
To observe the clinical efficacy of “Feiji Decoction” in the treatment of non small cell lung cancer(NSCLC), 102 subjects were randomized into two groups: observation group in which 61 cases were treated with “Feiji Decoction” and chemotherapy and control group in which 41 cases were treated with simple chemotherapy. The clinical symptoms, survival quality scale and specific lung cancer module were observed. Results: After treatment, the symptoms were alleviated in observation group and tended to worsen in control group. Conclusion: “Feiji Decoction” can relieve NSELC symptoms and its chemotherapeutic symptoms.
Key concepts: Medicine, Decoction, Lung cancer, Chemotherapy, Internal medicine, Traditional Chinese medicine, Cancer, Clinical efficacy